A phase 3 multicenter randomized staudy of Atezolizumab vs placebo administered in combination with Paclitaxel,Carboplatin and Bevacizumab to patients with newly diagnosed stage III or stage IV ovarian, fallopian tube or primary peritoneal cancer
Trial Number
NCT03038100 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Ovarian
Lead Cooperative Group
Participating Groups
GOG-F